Skip Navigation
Menu
Editorials |15 February 1989

Disease Associated with Clostridium difficile Infection

Dale N. Gerding, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
Grant Support: Supported in part by the U.S. Veterans Administration.
Requests for Reprints: Dale N. Gerding, MD, VA Medical Center, One Veterans Drive, Minneapolis, MN 55417.
Annals of Internal Medicine. 1989;110:255-257.
  • Veterans Administration Medical Center
    and
    University of Minnesota Medical School

    Minneapolis, Minnesota
×
FULL TEXT
Grant Support: Supported in part by the U.S. Veterans Administration.
Requests for Reprints: Dale N. Gerding, MD, VA Medical Center, One Veterans Drive, Minneapolis, MN 55417.
Annals of Internal Medicine. 1989;110:255-257.
FULL TEXT
PDF
Not Available
Citations
Citation

Gerding DN. Disease Associated with Clostridium difficile Infection. Ann Intern Med. 1989;110:255–257. doi: 10.7326/0003-4819-110-4-255

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 1989;110(4):255-257.

DOI: 10.7326/0003-4819-110-4-255

78 Citations

Related Articles
Increasing Incidence of Multiply Recurrent Clostridium difficile Infection in the United States: A Cohort Study
Annals of Internal Medicine; 167 (3): 152-158
Fool Me Thrice: The Evolving Story of Multiply Recurrent Clostridium difficile Infection
Annals of Internal Medicine; 167 (3): 202-203
In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks
Annals of Internal Medicine; 166 (10): JC53
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial
Annals of Internal Medicine; 165 (9): 609-616
View MoreView Less

Journal Club
In C difficile infection, adding IV bezlotoxumab to standard antibiotics reduced recurrence at 12 weeks
Annals of Internal Medicine; 166 (10): JC53
Review: Proton-pump inhibitors are associated with increased risk for Clostridium difficile infection
Annals of Internal Medicine; 157 (4): JC2-13
Review: Fidaxomicin is better than vancomycin for Clostridium difficile recurrence
Annals of Internal Medicine; 156 (8): JC4-9
View MoreView Less

Related Point of Care
Clostridioides difficile Infection
Annals of Internal Medicine; 169 (7): ITC49-ITC64
Clostridium difficile Infection
Annals of Internal Medicine; 153 (7): ITC4-1
View MoreView Less

Related Topics
Infectious Disease

Infectious Disease.

PubMed Articles
Using endogenous CRISPR-Cas system for genome editing in the human pathogen Clostridium difficile.
Appl Environ Microbiol 2019.
Clostridium difficile infection associated with metronidazole-based treatment for Helicobacter pylori eradication.
Gastroenterol Hepatol 2019.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×